Current research in empirical therapy for febrile neutropenia in cancer patients: what should be necessary and what is going on

Author： Castagnola Elio   Mikulska Malgorzata   Barabino Paola   Lorenzi Ines   Haupt Riccardo   Viscoli Claudio  

Publisher： Informa Healthcare

ISSN： 1472-8214

Source： Expert Opinion on Emerging Drugs, Vol.18, Iss.3, 2013-09, pp. : 263-278

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical and Economic Considerations of Empirical Antibacterial Therapy of Febrile Neutropenia in Cancer

By Dranitsaris G.  

PharmacoEconomics, Vol. 16, Iss. 4, 1999-10 ,pp. : 343-353

Adis International

Access to resources Recommend Favorite

Voriconazole: appropriate empirical therapy in febrile neutropenia?

By  

Inpharma, Vol. 1, Iss. 1323, 2002-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Critical appraisal of clinical practice guidelines for adult cancer patients with febrile neutropenia

By  

International Journal Of Pharmacy Practice, Vol. 26, Iss. 1, 2018-02 ,pp. : 49-54

John Wiley & Sons Inc

Access to resources Recommend Favorite

Liposomal Amphotericin B: A Review of its Use as Empirical Therapy in Febrile Neutropenia and in the Treatment of Invasive Fungal Infections

By Moen Marit D.   Lyseng-Williamson Katherine A.   Scott Lesley J.  

Drugs, Vol. 69, Iss. 3, 2009-02 ,pp. : 361-392

Adis International

Access to resources Recommend Favorite

Outpatient Therapy for Febrile Neutropenia: Clinical and Economic Implications

By de Lalla F.  

PharmacoEconomics, Vol. 21, Iss. 6, 2003-01 ,pp. : 397-413

Adis International

Access to resources Recommend Favorite